Iron is an essential micronutrient for microbial life. At the start of an infection the host environment will normally restrict available iron, and innate immune responses will aim to further reduce iron, thus inhibiting growth of potential pathogens. Successful pathogens have developed a variety of mechanisms to acquire iron from the available in vivo sources, using remote and direct capture, to render their environment iron replete. Iron restriction, and the presence of host iron sources like haem, are important drivers of gene regulation controlling the expression of numerous virulence factors. As an infection progresses the changing iron environment will therefore influence pathogen gene expression and trigger new activities. Understanding how bacteria acquire iron, and how iron acquisition affects the bacteria, has identified vaccine and antibiotic drug targets and is now suggesting novel approaches to control and treat infection.
AndrewsS.C., RobinsonA.K., and Rodriguez-QuinonesF. (2003) Bacterial iron homeostasis. FEMS Microbiol. Rev., 27, 215–237.
2.
CrichtonR. (2001) Inorganic biochemistry of iron metabolism: from molecular mechanisms to clinical consequences, 2nd edn, Chap. 8, p. 191. Wiley, New York.
3.
AndrewsN.C. (2008) Forging a field: the golden age of iron biology. Blood, 112, 219–230.
4.
WeinbergE.D. (2009) Iron availability and infection. Biochim. Biophys. Acta, 1790, 600–605.
5.
CassatJ.E., and SkaarE.P. (2013) Iron in infection and immunity. Cell Host Microbe, 13, 509–519.
6.
KhanF.A., FisherM.A., and KhakooR.A. (2007) Association of hemochromatosis with infectious diseases: expanding spectrum. Int. J. Infect. Dis., 11, 482–487.
7.
DrakesmithH., and PrenticeA.M. (2012) Hepcidin and the iron-infection axis. Science, 338, 768–772.
8.
PeyssonnauxC., ZinkernagelA.S., DattaV., LauthX., JohnsonR.S., and NizetV. (2006) TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood, 107, 3727–3732.
9.
ByrdT.F., and HorwitzM.A. (1993) Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J. Clin. Invest., 91, 969–976.
10.
WeissG. (2005) Modification of iron regulation by the inflammatory response. Best Pract. Res. Clin. Haematol., 18, 183–201.
11.
GruenheidS., PinnerE., DesjardinsM., and GrosP. (1997) Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome. J. Exp. Med., 185, 717–730.
12.
GovoniG., GauthierS., BilliaF., IscoveN.N., and GrosP. (1997) Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo.J. Leukoc. Biol., 62, 277–286.
13.
CellierM.F., CourvilleP., and CampionC. (2007) Nramp1 phagocyte intracellular metal withdrawal defense. Microbes Infect., 9, 1662–1670.
14.
Centers for Disease Control and Prevention (CDC). (2011) Fatal laboratory-acquired infection with an attenuated Yersinia pestis Strain–Chicago, Illinois, 2009. Morb. Mortal. Wkly. Rep., 60, 201–205.
15.
GerhardG.S., ChokshiR., StillC.D., BenottiP., WoodG.C., Freedman-WeissM., RiderC., and PetrickA.T. (2011) The influence of iron status and genetic polymorphisms in the HFE gene on the risk for postoperative complications after bariatric surgery: a prospective cohort study in 1,064 patients. Patient Saf. Surg., 5, 1–9.
16.
XiongA., SinghV.K., CabreraG., and JayaswalR.K. (2000) Molecular characterization of the ferric-uptake regulator, Fur, from Staphylococcus aureus.Microbiology, 146, 659–668.
17.
PrinceR.W., CoxC.D., and VasilM.L. (1993) Coordinate regulation of siderophore and exotoxin A production: molecular cloning and sequencing of the Pseudomonas aeruginosa fur Gene. J. Bacteriol., 175, 2589–2598.
18.
EscolarL., Pérez-MartinJ., and de LorenzoV. (1999) Opening the iron box: transcriptional metalloregulation by the Fur protein. J. Bacteriol., 181, 6223–6229.
19.
RanjanS., YellaboinaS., and RanjanA. (2006) IdeR in mycobacteria: from target recognition to physiological function. Crit. Rev. Microbiol., 32, 69–75.
20.
MoustafaM., AronoffG.R., ChandranC., HartzelJ.S., SmugarS.S., GalphinC.M., MaillouxL.U., BrownE., DinubileM.J., KartsonisN.A., and GurisD. (2012) Phase IIa study of the immunogenicity and safety of the novel Staphylococcus aureus vaccine V710 in adults with end-stage renal disease receiving hemodialysis. Clin. Vaccine Immunol., 19, 1509–1516.
21.
BrumbaughA.R., SmithS.N., and MobleyH.L. (2013) Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect. Immun., 81, 3309–3316.
22.
NandalA., HugginsC.C., WoodhallM.R., McHughJ., Rodríguez-QuiñonesF., QuailM.A., GuestJ.R., and AndrewsS.C. (2010) Induction of the ferritin gene (ftnA) of Escherichia coli by Fe(2+)-Fur is mediated by reversal of H-NS silencing and is RyhB independent. Mol. Microbiol., 75, 637–657.
23.
TroxellB., and HassanH.M. (2013) Transcriptional regulation by Ferric Uptake Regulator (Fur) in pathogenic bacteria. Front. Cell. Infect. Microbiol., 3, 1–13.
GanczH., CensiniS., and MerrellD.S. (2006) Iron and pH Homeostasis Intersect at the Level of Fur Regulation in the Gastric Pathogen Helicobacter pylori. Infect. Immun., 74, 602–614.
26.
ZanottiG., and CendronL. (2010) Functional and structural aspects of Helicobacter pylori acidic stress response factors. IUBMB Life, 62, 715–723.
27.
JohnsonM., SenguptaM., PurvesJ., TarrantE., WilliamsP.H., CockayneA., MuthaiyanA., StephensonR., LedalaN., WilkinsonB.J., JayaswalR.K., and MorrisseyJ.A. (2011) Fur is required for the activation of virulence gene expression through the induction of the sae regulatory system in Staphylococcus aureus.Int. J. Med. Microbiol., 301, 44–52.
28.
MasséE., and GottesmanS. (2002) A small RNA regulates the expression of genes involved in iron metabolism in Escherichia coli.Proc. Natl. Acad. Sci. USA, 99, 4620–4625.
29.
TorresV.J., AttiaA.S., MasonW.J., HoodM.I., CorbinB.D., BeasleyF.C., AndersonK.L., StauffD.L., McDonaldW.H., ZimmermanL.J., FriedmanD.B., HeinrichsD.E., DunmanP.M., and SkaarE.P. (2010) Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia. Infect. Immun., 78, 1618–1628.
30.
MittalR., SharmaS., ChhibberS., and HarjaiK. (2008) Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. J. Biomed. Sci., 15, 731–741.
31.
RosenD.A, HootonT.M., StammW.E., HumphreyP.A., and HultgrenS.J. (2007) Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med., 4, e329.
32.
RoweM.C., WithersH.L., and SwiftS. (2010) Uropathogenic Escherichia coli forms biofilm aggregates under iron restriction that disperse upon the supply of iron. FEMS Microbiol. Lett., 307, 102–109.
33.
O'TooleG., KaplanH.B., and KolterR. (2000) Biofilm formation as microbial development. Annu. Rev. Microbiol., 54, 49–79.
34.
Hall-StoodleyL., and StoodleyP. (2005) Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol., 13, 7–10.
35.
FuxC.A, CostertonJ.W., StewartP.S., and StoodleyP. (2005) Survival strategies of infectious biofilms. Trends Microbiol., 13, 34–40.
36.
JohnsonM., CockayneA., WilliamsP.H., and MorrisseyJ.A. (2005) Iron-responsive regulation of biofilm formation in Staphylococcus aureus involves Fur-Dependent and Fur-independent mechanisms. J. Bacteriol., 187, 8211–8215.
37.
DeightonM., and BorlandR. (1993) Regulation of slime production in Staphylococcus epidermidis by iron limitation. Infect. Immun., 61, 4473–4479.
38.
MuskD.J., BankoD.A., and HergenrotherP.J. (2005) Iron salts perturb biofilm formation and disrupt existing biofilms of Pseudomonas aeruginosa.Chem. Biol., 12, 789–796.
39.
GlickR., GilmourC., TremblayJ., SatanowerS., AvidanO., DézielE., GreenbergE.P., PooleK., and BaninE. (2010) Increase in rhamnolipid synthesis under iron-limiting conditions influences surface motility and biofilm formation in Pseudomonas aeruginosa.J. Bacteriol., 192, 2973–2980.
40.
BaninE., VasilM.L., and GreenbergE.P. (2005) Iron and Pseudomonas aeruginosa biofilm formation. Proc. Natl. Acad. Sci. USA, 102, 11076–11081.
41.
Moreau-MarquisS., BombergerJ.M., AndersonG.G., Swiatecka-UrbanA., YeS., O'TooleG.A., and StantonB.A. (2008) The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am. J. Physiol. Lung Cell. Mol. Physiol., 295, L25–37.
42.
ReidD.W., CarrollV., O'MayC., ChampionA., and KirovS.M. (2007) Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis. Eur. Respir. J., 30, 286–292.
43.
RossiM.S., PaquelinA., GhigoJ.M., and WandersmanC. (2003) Haemophore-mediated signal transduction across the bacterial cell envelope in Serratia marcescens: the inducer and the transported substrate are different molecules. Mol. Microbiol., 48, 1467–1480.
44.
HaleyK.P., and SkaarE.P. (2012) A battle for iron: host sequestration and Staphylococcus aureus acquisition. Microbes Infect., 14, 217–227.
45.
NoinajN., BuchananS.K., and CornelissenC.N. (2012) The transferrin-iron import system from pathogenic Neisseria species. Mol. Microbiol., 86, 246–257.
46.
BrockJ.H., WilliamsP.H., LicéagaJ., and WooldridgeK.G. (1991) Relative availability of transferrin-bound iron and cell-derived iron to aerobactin-producing and enterochelin-producing strains of Escherichia coli and to other microorganisms. Infect. Immun., 59, 3185–3190.
47.
RatledgeC., and DoverL.G. (2000) Iron metabolism in pathogenic bacteria. Annu. Rev. Microbiol., 54, 881–941.
48.
SnyderJ.A., HaugenB.J., BucklesE.L., LockatellC.V., JohnsonD.E., DonnenbergM.S., WelchR.A., and MobleyH.L. (2004) Transcriptome of uropathogenic Escherichia coli during urinary tract infection. Infect. Immun., 72, 6373–6381.
49.
HaganE.C., LloydA.L., RaskoD.A., FaerberG.J., and MobleyH.L. (2010) Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS Pathog., 6, e1001187.
50.
DateS.V., ModrusanZ., LawrenceM., MorisakiJ.H., ToyK., ShahI.M., KimJ., ParkS., XuM., BasuinoL., ChanL., ZeitschelD., ChambersH.F., TanM.W., BrownE.J., DiepB.A., and HazenbosW.L. (2014) Global gene expression of methicillin-resistant Staphylococcus aureus USA300 during human and mouse infection. J. Infect. Dis., 209, 1542–1550.
51.
SkvortsovT.A., IgnatovD.V., MajorovK.B., AptA.S., and AzhikinaT.L. (2013) Mycobacterium tuberculosis transcriptome profiling in mice with genetically different susceptibility to tuberculosis. Acta Naturae, 5, 62–69.
52.
RyndakM.B., SinghK.K., PengZ., Zolla-PaznerS., LiH., MengL., and LaalS. (2014) Transcriptional Profiling of Mycobacterium tuberculosis Replicating Ex vivo in Blood from HIV- and HIV+ Subjects. PLoS One, 9, e94939.
53.
KoningsA.F., MartinL.W., SharplesK.J., RoddamL.F., LathamR., ReidD.W., and LamontI.L. (2013) Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect. Immun., 81, 2697–2704.
54.
BrzuszkiewiczE., BrüggemannH., LiesegangH., EmmerthM., OlschlägerT., NagyG., AlbermannK., WagnerC., BuchrieserC., EmodyL., GottschalkG., HackerJ., and DobrindtU. (2006) How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc. Natl. Acad. Sci. USA, 103, 12879–12884.
55.
WelchR.A., BurlandV., PlunkettG.3rd, RedfordP., RoeschP., RaskoD., BucklesE.L., LiouS.R., BoutinA., HackettJ., StroudD., MayhewG.F., RoseD.J., ZhouS., SchwartzD.C., PernaN.T., MobleyH.L., DonnenbergM.S., and BlattnerF.R. (2002) Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli.Proc. Natl. Acad. Sci. USA., 99, 17020–17024.
56.
HaganE.C., and MobleyH.L. (2009) Haem acquisition is facilitated by a novel receptor Hma and required by uropathogenic Escherichia coli for kidney infection. Mol. Microbiol., 71, 79–91.
57.
GarciaE.C., BrumbaughA.R., and MobleyH.L. (2011) Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect. Immun., 79, 1225–1235.
58.
TorresA.G., RedfordP., WelchR.A., and PayneS.M. (2001) TonB-dependent systems of uropathogenic Escherichia coli: aerobactin and heme transport and TonB are required for virulence in the mouse. Infect. Immun., 69, 6179–6185.
59.
SkaarE.P., HumayunM., BaeT., DeBordK.L., and SchneewindO. (2004) Iron-source preference of Staphylococcus aureus infections. Science, 305, 1626–1628.
60.
TorresV.J., StauffD.L., PishchanyG., BezbradicaJ.S., GordyL.E., IturreguiJ., AndersonK.L., DunmanP.M., JoyceS., and SkaarE.P. (2007) A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence. Cell Host Microbe, 1, 109–119.
61.
ReigstadC.S., HultgrenS.J., and GordonJ.I. (2007) Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J. Biol. Chem., 282, 21259–21267.
62.
TanC.K., CareyA.J., CuiX., WebbR.I., IpeD., CrowleyM., CrippsA.W., BenjaminW.H.Jr., UlettK.B., SchembriM.A., and UlettG.C. (2012) Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection. Infect. Immun., 80, 3145–3160.
63.
DuellB.L., CareyA.J., TanC.K., CuiX., WebbR.I., TotsikaM., SchembriM.A., DerringtonP., Irving-RodgersH., BrooksA.J., CrippsA.W., CrowleyM., and UlettG.C. (2012) Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. J. Immunol., 188, 781–792.
64.
FloT.H., SmithK.D., SatoS., RodriguezD.J., HolmesM.A., StrongR.K., AkiraS., and AderemA. (2004) Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature, 432, 917–921.
65.
FischbachM.A., LinH., ZhouL., YuY., AbergelR.J., LiuD.R., RaymondK.N., WannerB.L., StrongR.K., WalshC.T., AderemA., and SmithK.D. (2006) The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc. Natl. Acad. Sci. USA, 103, 16502–16507.
66.
OjhaA.K., BaughnA.D., SambandanD., HsuT., TrivelliX., GuerardelY., AlahariA., KremerL., JacobsW.R., and HatfullG.F. (2008) Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol., 69, 164–174.
67.
OjhaA., and HatfullG.F. (2007) The role of iron in Mycobacterium smegmatis biofilm formation: the exochelin siderophore is essential in limiting iron conditions for biofilm formation but not for planktonic growth. Mol. Microbiol., 66, 468–483.
MislinG.L., and SchalkI.J. (2014) Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa.Metallomics, 6, 408–420.
71.
YepA., McQuadeT., KirchhoffP., LarsenM., and MobleyH.L. (2014) Inhibitors of TonB function identified by a high-throughput screen for inhibitors of iron acquisition in uropathogenic Escherichia coli CFT073. MBio, 5, e01089–13.
72.
DeriuE., LiuJ.Z., PezeshkiM., EdwardsR.A., OchoaR.J., ContrerasH., LibbyS.J., FangF.C., and RaffatelluM. (2013) Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe, 14, 26–37.
73.
MuskD.J.Jr., and HergenrotherP.J. (2008) Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung. J. Appl. Microbiol., 105, 380–388.
74.
ReidD.W., O'MayC., RoddamL.F., and LamontI.L. (2009) Chelated iron as an anti-Pseudomonas aeruginosa biofilm therapeutic strategy. J. Appl. Microbiol., 106, 1058.
